Cargando…
CD36(+) Fibroblasts Secrete Protein Ligands That Growth-Suppress Triple-Negative Breast Cancer Cells While Elevating Adipogenic Markers for a Model of Cancer-Associated Fibroblast
Tumor and stroma coevolve to facilitate tumor growth. Hence, effective tumor therapeutics would not only induce growth suppression of tumor cells but also revert pro-tumor stroma into anti-tumoral type. Previously, we showed that coculturing triple-negative or luminal A breast cancer cells with CD36...
Autores principales: | Jabbari, Kosar, Cheng, Qingsu, Winkelmaier, Garrett, Furuta, Saori, Parvin, Bahram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654220/ https://www.ncbi.nlm.nih.gov/pubmed/36361532 http://dx.doi.org/10.3390/ijms232112744 |
Ejemplares similares
-
Protein Ligands in the Secretome of CD36(+) Fibroblasts Induce Growth Suppression in a Subset of Breast Cancer Cell Lines
por: Jabbari, Kosar, et al.
Publicado: (2021) -
Influence of Simulated Microgravity on Mammary Epithelial Cells Grown as 2D and 3D Cultures
por: Winkelmaier, Garrett, et al.
Publicado: (2023) -
Fusion of encoder-decoder deep networks improves delineation of multiple nuclear phenotypes
por: Khoshdeli, Mina, et al.
Publicado: (2018) -
ERα36-High Cancer-Associated Fibroblasts as an Unfavorable Factor in Triple-Negative Breast Cancer
por: Nagel, Anna, et al.
Publicado: (2022) -
Biomarkers of Tumor Heterogeneity in Glioblastoma Multiforme Cohort of TCGA
por: Winkelmaier, Garrett, et al.
Publicado: (2023)